Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

 

Category: Pharmacology

Vitamin Treatment and Renin-Angiotensin System Inhibition in Patients with COVID-19

During this 1-hour activity expert faculty from the American Society of Health-System Pharmacists and the Society of Critical Care Medicine discussed the use of vitamins as adjunctive treatment in patients with COVID-19 as well as the role of Renin-Angiotensin System Inhibitio...

   Estimated Time: 01:02:49 min Coronavirus, COVID-19, Therapies

Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019–Induced Vasodilatory Shock: A Retrospective Matched Cohort Study

From Critical Care Explorations. In this study, the authors found that angiotensin-II treatment for coronavirus disease 2019–induced distributive shock was associated with rapid improvement in multiple physiologic indices and that angiotensin-II in coronavirus disease 2019–ind...

   Estimated Time: 25:46 min Coronavirus, COVID-19, Shock, Therapies

Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients

From Critical Care Explorations. In this study, the authors examined the outcomes of critically ill coronavirus disease 2019 patients treated with tocilizumab and factors associated with clinical improvement.

   Estimated Time: 23:36 min Coronavirus, COVID-19, Therapies, Ventilatory Support

Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy

From Critical Care Explorations. In this study, the authors gathered available published resources including physicochemical and pharmacokinetic properties and suggest antiviral drug dosing adaptation for coronavirus disease 2019–infected critically ill patients receiving extr...

   Estimated Time: 14:12 min Coronavirus, COVID-19, ECMO, Therapies, Virology

Dexmedetomidine-Associated Hyperpyrexia in Three Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Explorations . In this study of three patients, the authors state that their findings suggest that high doses of dexmedetomidine infusion are associated with hyperpyrexia in a seemingly dose-dependent fashion in critically ill patients with coronavirus dise...

   Estimated Time: 15:48 Coronavirus, COVID-19, Therapies

Relocating IV Pumps for Critically Ill Isolated Coronavirus Disease 2019 Patients From Bedside to Outside the Patient Room

From Critical Care Explorations. The authors discuss advantages and disadvantages of relocating IV pumps for coronavirus disease 2019 patients from bedside to outside the patient room and characterize reproducible details of an external infusion pump model.

   Estimated Time: 12:09 min Coronavirus, COVID-19, ICU Design

Letter to Editor: In Response to "Coagulopathy of Coronavirus Disease 2019"

From Critical Care Medicine. This Letter to the Editor is in response to the article "Coagulopathy of Coronavirus 2019" by Iba et a.

   Estimated Time: 03:21 min Anticoagulation, Coronavirus, COVID-19

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

From Critical Care Explorations. In this narrative review, the authors summarize existing knowledge of the immune response to coronavirus infection and highlight the current and potential future roles of therapeutic strategies to combat the hyperinflammatory response of patien...

   Estimated Time: 31:38 min Coronavirus, COVID-19, Therapies

COVID-19: Critical Care Medicine Experts International Summit

The webcast invited China and US critical care medicine top leaders and experts to discuss issues of common concerns in managing the COVID-19 patients in three different sessions, including Mechanical Ventilation, Critical Care Nutrition, and Steroid Therapy.

   Estimated Time: 02:28:16 min Coronavirus, COVID-19, Nutrition, Sedation, Therapies, Ventilatory Support

Renin-Angiotensin System and COVID-19

This presentation is a review of the renin-angiostensin System and COVID-19. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 06:55 min Coronavirus, COVID-19, Therapies

COVID-19 Pharmacology Debates: Management of Delirium, Pain and Sedation

The Society of Critical Care Medicine (SCCM) and the American Society of Health-System Pharmacists (ASHP) in their third series of therapeutic debates in the management of COVID-19.

   Estimated Time: 01:02:37 min Coronavirus, COVID-19, Sedation, Therapies

COVID-19 Pharmacology Debates: Steroid and Antiviral Use in COVID-19 Patients

ASHP and the SCCM teamed up in their second series of therapeutic debates in the management of COVID-19. In the first debate, the content matter experts reviewed the latest literature and debate the use of steroids for treatment of COVID-19.

   Estimated Time: 01:01:56 min Antivirals, Coronavirus, COVID-19, Steroids, Therapies
   Estimated Time: 07:40 min ARDS, Coronavirus, COVID-19, Therapies

Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation

From Critical Care Medicine. Deep venous thrombosis is very common in critically ill patients with coronavirus disease 2019, so the authors describe the prevalence of venous thromboembolism in critically ill patients receiving different regimens of prophylactic anticoagulation.

   Estimated Time: 10:28 min Anticoagulation, Coronavirus, COVID-19

Letter to the Editor: Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Medicine. This Letter to the Editor is in response to an article by Iba et al. (Coagulopathy of Coronavirus Disease 2019) and discusses dosing recommendations of low molecular weight heparin.

   Estimated Time: 02:00 min Coronavirus, COVID-19, Therapies

Procedures for COVID-19 Cohort Units: Building an Operating Room in a COVID-19 Cohort ICU

This presentation provides procedures for building COVID-19 cohort units. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 09:48 min Coronavirus, COVID-19, Disaster Preparedness, Infection Control

Letter to the Editor: Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Explorations. In this Letter to the Editor, the authors report their adapted thromboprophylaxis practice of low-molecular-weight heparin administration in coronavirus disease 2019 ICU patients.

   Estimated Time: 07:04 min Coronavirus, COVID-19, Therapies

Anticoagulation guidelines for COVID 19 patients

This resource details anticoagulation guidelines for COVID-19 patients. This is a community developed COVID-19 microlearning resource.

   Estimated Time: 02:25 min Anticoagulation, Coronavirus, COVID-19, Therapies

Alternative Analgesic and Sedative Agents in the Setting of Drug Shortages during the COVID19 Pandemic

This resources detail how to manage drug shortages for alternative analgesics and sedagent agents. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 10:30 min Coronavirus, COVID-19, Resource Allocation, Therapies, Triage

What data support the use of convalescent plasma? Do you have experience with it? Which patients should be treated with it?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on July 8th, 2020.

   Estimated Time: 08:18 min coronavirus, COVID-19, Therapies